{"title": "Frecuencia de las reacciones al\u00e9rgicas a la vacuna triple viral en pacientes con alergia al huevo", "author": "Jorge S\u00e1nchez; Ruth Ram\u00edrez; Ricardo Cardona", "url": null, "hostname": null, "description": "Introduction: Vaccination is the most effective public health intervention of all times, reducing the death and morbidity rates derived from multiple infectious diseases. In many cases, the administration and reception of vaccines is delayed due to the fear of allergic reactions; this is frequent among patients with allergy to egg who need the triple viral vaccine.Objective: To evaluate the frequency of reactions after the administration of triple viral vaccine (Measles, Mumps and Rubella, MMR) in an egg-allergic population.Materials and methods: We conducted a multi-center retrospective study (2014-2016) including patients with egg allergy who visited an allergology center and required the administration of the triple viral vaccine.Results: A total of 94 patients met the selection criteria. From these patients, 68.2% had cutaneous symptoms, 22.3% had an anaphylactic reaction, 5.3% had gastrointestinal symptoms, and 4.2% had respiratory egg-related symptoms. Regardless of the severity of their reaction to egg, all patientsreceived the triple viral vaccine and in 100% of the cases, it was well tolerated.Conclusion: Although egg allergy is common in childhood, the risk of allergic reactions during the MMR vaccination in this population was similar to that in the general population, therefore, its use should not be deferred even in patients with a history of severe egg-related allergic reactions.", "sitename": "Biom\u00e9dica", "date": "2018-12-01", "cleaned_text": "Frecuencia de las reacciones al\u00e9rgicas a la vacuna triple viral en pacientes con alergia al huevo Resumen Introducci\u00f3n. La vacunaci\u00f3n es la intervenci\u00f3n en salud p\u00fablica m\u00e1s efectiva de todos los tiempos, pues reduce la mortalidad y la morbilidad de m\u00faltiples enfermedades infecciosas. En muchas ocasiones, la aplicaci\u00f3n de las vacunas se retrasa por el temor a las reacciones al\u00e9rgicas, lo cual es frecuente entre los pacientes con alergia al huevo que requieren la vacuna triple viral (rubeola-sarampi\u00f3n-parotiditis). Objetivo. Evaluar la frecuencia de reacciones despu\u00e9s de la aplicaci\u00f3n de la vacuna triple viral en una poblaci\u00f3n al\u00e9rgica al huevo. Materiales y m\u00e9todos. Se hizo un estudio retrospectivo multic\u00e9ntrico (2014-2016) de pacientes con alergia al huevo que acudieron a centros de alergolog\u00eda de Medell\u00edn y requer\u00edan la aplicaci\u00f3n de la vacuna triple viral. Resultados. Noventa y cuatro pacientes cumpl\u00edan los criterios de selecci\u00f3n; 68,2 % de ellos presentaba s\u00edntomas cut\u00e1neos al consumir huevo; 22,3 %, reacci\u00f3n anafil\u00e1ctica; 5,3 %, s\u00edntomas gastrointestinales, y 4,2 %, s\u00edntomas respiratorios. Independientemente de la gravedad de su reacci\u00f3n al huevo, todos los pacientes recibieron la vacuna triple viral y la toleraron bien. Conclusi\u00f3n. Aunque la alergia al huevo es frecuente en la edad infantil, el riesgo de reacciones al\u00e9rgicas despu\u00e9s de aplicar la vacuna triple viral en esta poblaci\u00f3n fue similar al de la poblaci\u00f3n general, por lo que no se debe diferir su aplicaci\u00f3n, incluso en pacientes con antecedentes de reacciones graves al huevo. Descargas Referencias bibliogr\u00e1ficas Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell the 21st century. EMBO Mol Med. 2014;6:708-20. [https://doi.org/10.1002/emmm.201403876](https://doi.org/10.1002/emmm.201403876) Whitney CG, Zhou F, Singleton J, Schuchat A. Centers for Disease Control and Prevention (CDC). Benefits from immunization during the vaccines for children program era - United States, MMWR Morb Mortal Wkly Removal of Gold M, Burgess M, Turnbull F, et al. Adverse events following immunisation associated with 1998 Australian Measles Control Campaign. Intell. 2000;24:27-33. Pool Yunginger JW, et IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics. 2002;110:e71. Andersen DV, J\u00f8rgensen IM. MMR vaccination of children egg allergy is Dan J. 2013;60:A4573. Fina-Avil\u00e9s Mart\u00ednez-G\u00f3mez Rodrigo-Pend\u00e1s JA, Lushchenkova Pim\u00f3s-Tella L, et al. MMR vaccine and egg allergy. Experience in a hospital immunization unit. An Pediatr et al. Adverse reactions following immunization with MMR vaccine in children at provinces of Iran. Arch Iran Med. 2011;14:91-5. [https://doi.org/011142/AIM.005](https://doi.org/011142/AIM.005) Fasano MB, Wood RA, Cooke SK, and adverse allergic to eggs. N Engl J Med. 1995;332:1262-6. [https://doi.org/10.1056/NEJM199505113321904](https://doi.org/10.1056/NEJM199505113321904) S\u00e1nchez J, Restrepo MN, Mop\u00e1n J, Chinchilla C, Cardona R. Alergia a la leche y al huevo: diagn\u00f3stico, manejo e implicaciones en Am\u00e9rica Latina. Biom\u00e9dica. 2014;34:143-56. [https://doi.org/10.7705/biomedica.v34i1.1677](https://doi.org/10.7705/biomedica.v34i1.1677) Algunos art\u00edculos similares: - Jorge S\u00e1nchez, Mar\u00eda Nelly Restrepo, Jos\u00e9 Mopan, Carlos Chinchilla, Ricardo Cardona, [Alergia a la leche y al huevo: diagn\u00f3stico, manejo e implicaciones en Am\u00e9rica Latina](https://revistabiomedica.org/index.php/biomedica/article/view/1677), [Biom\u00e9dica: Vol. 34 N\u00fam. 1 (2014)](https://revistabiomedica.org/index.php/biomedica/issue/view/127) - Jorge Mario S\u00e1nchez, Ruth Helena Ram\u00edrez, Liliana Mar\u00eda Tamayo, Carlos Fernando Chinchilla, Ricardo Cardona, [Urticaria por fr\u00edo: serie de casos y revisi\u00f3n del tema](https://revistabiomedica.org/index.php/biomedica/article/view/298), [Biom\u00e9dica: Vol. 31 N\u00fam. 2 (2011)](https://revistabiomedica.org/index.php/biomedica/issue/view/19) - Mar\u00eda Victoria Ovalle, Clara I. Agudelo, N\u00e9lida Mu\u00f1oz, Elizabeth Casta\u00f1eda, Carmen R. Gallego, Sandra N\u00fa\u00f1ez, Edilma Jaramillo, Vianey Emilce Portilla, Mercedes Cano, Martha Gartner, Mar\u00eda Helena Alvarez, Gladys Mora, Patricia Rinc\u00f3n, Martha Uzeta, [Vigilancia de los serotipos y susceptibilidad antimicrobiana de Haemophilus influenzae en Colombia, 1994-2002.](https://revistabiomedica.org/index.php/biomedica/article/view/1211), [Biom\u00e9dica: Vol. 23 N\u00fam. 2 (2003)](https://revistabiomedica.org/index.php/biomedica/issue/view/72) - Doris Cardona, Mar\u00eda Osley Garz\u00f3n, Mateo Calle, Maite Catalina Agudelo, \u00c1ngela Segura, [Tendencia de la mortalidad y la morbilidad por tos ferina en Colombia, 2002-2012](https://revistabiomedica.org/index.php/biomedica/article/view/3117), [Biom\u00e9dica: Vol. 36 N\u00fam. 3 (2016)](https://revistabiomedica.org/index.php/biomedica/issue/view/146) - Jorge S\u00e1nchez, Ricardo Cardona, Luis Caraballo, Carlos Serrano, Ruth Ram\u00edrez, Susana D\u00edez, Elizabeth Garc\u00eda, Ana Mar\u00eda Segura, Alfonso Cepeda, Mar\u00eda Minotas, [Inmunoterapia con al\u00e9rgenos: mecanismos de acci\u00f3n, impacto terap\u00e9utico y socioecon\u00f3mico. Consenso de la Asociaci\u00f3n Colombiana de Alergias, Asma e Inmunolog\u00eda](https://revistabiomedica.org/index.php/biomedica/article/view/3183), [Biom\u00e9dica: Vol. 36 N\u00fam. 3 (2016)](https://revistabiomedica.org/index.php/biomedica/issue/view/146) - Stefany Monsalve, Santiago Rucinque, Luis Polo, Gina Polo, [Evaluaci\u00f3n de la accesibilidad espacial a los puestos de la campa\u00f1a de vacunaci\u00f3n antirr\u00e1bica en Bogot\u00e1, Colombia](https://revistabiomedica.org/index.php/biomedica/article/view/3074), [Biom\u00e9dica: Vol. 36 N\u00fam. D. Cer\u00f3n, Rugeles, Francisco J. D\u00edaz , [Reporte de un brote de infecci\u00f3n por SARS-CoV-2 por transmisi\u00f3n a\u00e9rea: evidencia epidemiol\u00f3gica y molecular](https://revistabiomedica.org/index.php/biomedica/article/view/6695), [Biom\u00e9dica: Vol. and challenges for physicians, 2019. "}